Shanghai OPM Biosciences Co (SHSE:688293) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Shanghai OPM Biosciences Co EBITDA Margin % Related Terms
Shanghai OPM Biosciences Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688293 vs VRTX, REGN, ALNY: EBITDA Margin % Comparison
For the Biotechnology subindustry, Shanghai OPM Biosciences Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai OPM Biosciences Co EBITDA Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai OPM Biosciences Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Shanghai OPM Biosciences Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai OPM Biosciences Co (SHSE:688293) has a EBITDA Margin % of 23.03% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shanghai OPM Biosciences Co and its competitors. This is 20% below median its historical median of 28.83. According to the industry distribution chart, Shanghai OPM Biosciences Co ranks #198 out of 944 companies in the Biotechnology industry, placing it in the top 21%.
Is Shanghai OPM Biosciences Co's EBITDA Margin % too high?
Shanghai OPM Biosciences Co's current EBITDA Margin % of 23.03% is 20% below median its 10-year median of 28.83. Based on the distribution chart, Shanghai OPM Biosciences Co ranks #198 out of 944 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai OPM Biosciences Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai OPM Biosciences Co's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai OPM Biosciences Co ranks #198 out of 944 companies for EBITDA Margin %. This places Shanghai OPM Biosciences Co in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shanghai OPM Biosciences Co and its competitors. Shanghai OPM Biosciences Co's current EBITDA Margin % is 23.03%, which is 20% below median its own 10-year median of 28.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai OPM Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai OPM Biosciences Co (SHSE:688293) is currently considered Fairly Valued. The stock's GF Value™ is ¥37.31, compared to a current price of ¥37.65 — trading 0.9% above its estimated fair value. The current EBITDA Margin % is 23.03%, which is 20% below median its 10-year median of 28.83. Shanghai OPM Biosciences Co's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Shanghai OPM Biosciences Co (SHSE:688293), the current EBITDA Margin % is 23.03% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai OPM Biosciences Co (SHSE:688293) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai OPM Biosciences Co stock appears to be overvalued.
The current stock price of ¥37.65 is trading 0.9% above its estimated GF Value™ of ¥37.31.
GuruFocus considers Shanghai OPM Biosciences Co to be Fairly Valued.
Key valuation signals for SHSE:688293:
EBITDA Margin %: 23.03% (20% below median its 10-year median of 28.83)
GF Value™: ¥37.31 vs. price of ¥37.65 (0.9% above fair value)
No single metric tells the full story. See the SHSE:688293 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688293 has been successfully added to your 
